← All companies

BLCO

Bausch + Lomb Corporation

BLCO NYSE Ophthalmic Goods EDGAR ↗

$16.77

-0.22 -1.29%

Key statistics

from XBRL data in SEC filings

Market cap

$5.99B

Revenue (TTM)

$5.32B

Net income (TTM)

-$171M

EPS (TTM)

$-0.48

P/E ratio

—

Dividend yield

—

Free cash flow

-$66.0M

Cash

$367M

Total assets

$13.9B

Gross margin

—

52-week range

$13.53 – $18.92

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Shareholder vote results May 20, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Results of operations (earnings release) Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Feb 18, 2026 8-K Results of operations (earnings release) Feb 18, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Other events Jan 2, 2026 8-K/A Director or officer change Dec 22, 2025 8-K Director or officer change Dec 17, 2025 8-K Other events Dec 12, 2025 8-K Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Terminated a material agreement; Director or officer change; Regulation FD disclosure Aug 18, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Results of operations (earnings release) Jul 30, 2025 8-K Director or officer change Jul 23, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Jun 27, 2025 8-K Other events Jun 18, 2025 8-K Other events Jun 10, 2025 8-K Shareholder vote results May 21, 2025 8-K Other events May 21, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Results of operations (earnings release) Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Feb 19, 2025 8-K Results of operations (earnings release) Feb 19, 2025 8-K Entered a material agreement; Took on a direct financial obligation Nov 1, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Results of operations (earnings release) Oct 30, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Director or officer change; Shareholder vote results May 29, 2024 10-Q Quarter ended 2024-03-31 May 1, 2024 8-K Results of operations (earnings release) May 1, 2024 8-K Director or officer change; Regulation FD disclosure Feb 28, 2024 10-K Fiscal year ended 2023-12-31 Feb 21, 2024 8-K Results of operations (earnings release) Feb 21, 2024 8-K/A Nov 13, 2023 8-K/A Director or officer change Nov 7, 2023